Peripheral Neurostimulation

November 5, 2026 updated by: Jean-Louis Horn, Stanford University

Peripheral nerve blocks are routinely used and highly successful for intra-operative anesthesia and post-operative pain management. Nerve blocks are guided using either neurostimulation as a means to localize the right nerve or by ultrasound guidance or combining the 2 methods. The purpose of this study is to assess whether electrical stimulation improves nerve block quality, beyond its simple purpose of nerve localization.

Study Overview

Detailed Description

The investigators wish to understand how electrical stimulation can affect local anesthetic disposition when performing a peripheral nerve block.

By studying this subject, the investigators open possibilities for improvement on many levels:

increasing the efficacy of the nerve block allows for a reduced onset time, reduced incidence of incomplete block, and prolonged duration of the local anesthetics. This allows for patients to fully benefit from the analgesic properties of the nerve block, allows for a decrease in delays for the operating room readiness, and a allows for a decrease in the amount of medication needed for a successful nerve block. This will decrease side effects and risks of the nerve blocks. Overall better post-surgical pain control may decrease risks for developing chronic post-operative pain, a major post-operative complication.

The results of this study will open the door to novel approaches to manage acute post-operative pain.

Study Type

Interventional

Enrollment (Estimated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Stanford, California, United States, 94305
        • Stanford University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Undergoing elective upper limb surgery with a planned brachial plexus nerve block

Exclusion Criteria:

  • Under 18 years old
  • ASA score above III
  • Chronic pain condition with daily milligrams of morphine equivalent > 30
  • Poorly controlled psychiatric condition
  • Coagulopathy
  • Active infection
  • Moderate, severe or progressing neuropathy
  • COPD/Chronic oxygen user
  • Pregnancy
  • Incarceration
  • Unable to consent
  • BMI > 35
  • Pacemaker

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ultrasound-guided brachial plexus block with peripheral nerve stimulation

Patients will receive a brachial plexus catheter with ultrasound guidance as per standard of care, with additional use of the B. Braun HNS 12 nerve stimulator during the loading dose of local anesthesia to maintain a gentle twitch.

Nerve stimulator that is traditionally used for nerve localization during block placements.

Sham Comparator: Ultrasound-guided brachial plexus block without peripheral nerve stimulation

Patients will receive the brachial plexus catheter in the same way the first arm would, and the B Braun nerve stimulator will be placed in the same way, but the ground electrode will not be connected to the patient.

Stimulator will be placed and turned on, but the grounding electrode will not be connected to prevent nerve stimulation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Onset of Motor Block
Time Frame: Within 1 hour after the block placement.

Determining time when patient experiences first symptoms of local anesthetic action on the upper trunk distribution (median or musculo cutaneous nerve)

Within 1 hour after the block placement.
Onset of Sensory Block
Time Frame: Within 1 hour after the block placement.

Determining time when patient experiences first symptoms of local anesthetic action on the superior trunk distribution over the shoulder.

Within 1 hour after the block placement.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skin Temperature Change
Time Frame: Immediately before and up to 1 hour after neurostimulation and nerve block is performed.

Measuring changes in skin temperature over the course of pre and post stimulation and nerve blocking between the blocked and unblocked arms, measured in degrees Celsius. Using Medline Temperature Sensor.

Immediately before and up to 1 hour after neurostimulation and nerve block is performed.
When Patient Experiences First Pain
Time Frame: up to day 7 post operatively

Time after surgery at which the patient experiences first sign of pain at the surgical site, as measured by the time for first local anesthetic bolus based on pump device history.

up to day 7 post operatively
Time of First Opioid Taken
Time Frame: Within the first 7 days after surgery

As measured by asking patients if they were taking opioids daily after surgery, up to one week.

Within the first 7 days after surgery
Total Post Operative MME/Opioid Usage at Day 1
Time Frame: On Post Operative Day 1

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 1
Total Post Operative MME/Opioid Usage at Day 2
Time Frame: On Post Operative Day 2

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 2
Total Post Operative MME Opioid Usage at Day 3
Time Frame: On Post Operative Day 3

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 3
Total Post Operative MME Opioid Usage at Day 4
Time Frame: On Post Operative Day 4

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 4
Total Post Operative MME Opioid Usage at Day 5
Time Frame: On Post Operative Day 5

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 5
Total Post Operative MME Opioid Usage at Day 6
Time Frame: On Post Operative Day 6

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 6
Opioid Usage Assessment at Day 7
Time Frame: On Post Operative Day 7

Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg).

On Post Operative Day 7
Opioid Usage Assessment at Day 28
Time Frame: On Post Operative Day 28

Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 3 weeks and 2) if so, how many pills per day.

On Post Operative Day 28
Opioid Usage Assessment at 6 Months
Time Frame: On Post Operative Month 6

Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 5 months and 2) if so, how many pills per day.

On Post Operative Month 6
Opioid Usage Assessment at 1 Year
Time Frame: On Post Operative 1 Year

Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 6 months and 2) if so, how many pills per day.

On Post Operative 1 Year
Quality of Recovery
Time Frame: At Post Operative days 7 and 28 , 6 months, and 1 year

Using the standardized -Quality of Recovery 15- at post operative days 7 and 28, 6 months, and 1 year. Each item count on a 0-10 scale where 0 is worst and 10 is best.

PART A How have you been feeling in the last 24 hours? (0 to 10, where 0 = none of the time [poor] and 10 = all of the time [excellent]) Q.1 Able to breathe easily Q.2 Been able to enjoy food Q.3 Feeling rested Q.4 Have had a good sleep Q.5 Able to look after personal toilet and hygiene unaided Q.6 Able to communicate with family or friends Q.7 Getting support from hospital doctors and nurses Q.8 Able to return to work or usual home activities Q.9 Feeling comfortable and in control Q.10 Having a feeling of general well-being

PART B Have you had any of the following in the last 24 hours? (10 to 0, where 10 = none of the time [excellent] and 0 = all of the time [poor]) Q.11 Moderate pain Q.12 Severe pain Q.13 Nausea or vomiting Q.14 Feeling worried or anxious Q.15 Feeling sad or depressed

At Post Operative days 7 and 28 , 6 months, and 1 year
General satisfaction
Time Frame: At post operative days 0, 1, 7, 28, 6 months, and 1 year

General satisfaction on a scale from 1-5 (extremely unsatisfied, unsatisfied, neutral, satisfy, extremely satisfied). Asking patients if they would receive the block again (Y/N).

At post operative days 0, 1, 7, 28, 6 months, and 1 year
Adverse Events
Time Frame: Asked to patients (Check all that apply) at Post Operative Day 0, 1, 7, 28, 6 Months, and 1 Year. Patients have the opportunity to specify in detail for each sympom they select.

Numbness, Weakness, Tingling, Breathing Difficulties, Hoarseness

Asked to patients (Check all that apply) at Post Operative Day 0, 1, 7, 28, 6 Months, and 1 Year. Patients have the opportunity to specify in detail for each sympom they select.
Catheter Duration Before Discontinuation
Time Frame: After surgery, up until catheter discontinuation.

Patients' catheter duration before discontinuation, as measured by Avoset pump device data.

After surgery, up until catheter discontinuation.
Total Local Anesthetic Use with Catheter
Time Frame: After surgery, up until catheter discontinuation.

Patients' local anesthetic use with catheter, as measured by Avoset pump device data.

After surgery, up until catheter discontinuation.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 23, 2025

Primary Completion (Estimated)

July 30, 2027

Study Completion (Estimated)

July 30, 2027

Study Registration Dates

First Submitted

August 7, 2024

First Submitted That Met QC Criteria

August 20, 2024

First Posted (Actual)

August 22, 2024

Study Record Updates

Last Update Posted (Actual)

November 10, 2026

Last Update Submitted That Met QC Criteria

November 5, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe